New Delhi, Feb 17: The National Technical Advisory Group on Immunization (NTAGI) is likely to make recommendations on India’s COVID-19 vaccination policy in around two weeks after evaluating data about the “value of all vaccines” and their “relative importance” in a case where more than 97 percent infection are due to Omicron variant of coronavirus.
This will help in making the country’s future strategy of COVID-19 vaccination and management, reported The Times of India citing sources.
According to the report, a senior official said “NTAGI is likely to make recommendations in around two weeks, based on which the government will take a call to modify the COVID-19 vaccination policy. A final decision is likely to be taken in early March.”
The evaluation and recommendation may influence the Centre’s decision on expansion of the COVID-19 immunisation programme and strategy on booster shots, said the report.
A total of 174.24 crore vaccine doses have been administered across the country so far. Of these, more than 34.75 lakh doses were administered on February 16, according to the health ministry’s update.
